Australian Medical Equipment Stock News

ANZ Group Holdings (ASX:ANZ) has drawn fresh attention after announcing the early redemption of A$1.25b in subordinated notes, along with a plan to consolidate its Singapore offices into a single Marina One location. See our latest analysis for ANZ Group Holdings. At a share price of A$36.4, ANZ’s recent corporate moves sit against a background of relatively muted short term share price returns. However, the 1 year and 5 year total shareholder returns of 25.02% and 96.67% point to a stronger...

Westgold Resources reported that group gold production rose to 111,418oz in the second quarter of fiscal 2026, up from 83,937oz in the first quarter, and it maintained full‑year production guidance at 345koz–385koz. This combination of stronger recent output and unchanged guidance suggests management sees current operational momentum as consistent with its full‑year plans. We will now examine how the confirmed full‑year production guidance shapes Westgold Resources’ investment narrative...

Market focus on inflation data and Wesfarmers’ upcoming results Wesfarmers (ASX:WES) returned to trading after the Australia Day break, with attention firmly on upcoming inflation data and its half year earnings on 19 February. This combination could influence sentiment around its retail exposure. See our latest analysis for Wesfarmers. At A$84.19, Wesfarmers’ 7 day share price return of 3.78% and 30 day share price return of 3.71% sit against a softer 90 day share price return of a 2.25%...

Inflation data and RBA decision move to the forefront for Westpac Westpac Banking (ASX:WBC) is in focus as traders await Australia’s December quarter CPI on Wednesday and the Reserve Bank of Australia’s policy update on 3 February. These are key inputs for interest rate expectations. Strong recent labour market figures have lifted the stakes for this inflation print, with investors watching how any shift in rate expectations could affect bank funding costs, net interest margins and credit...

Investors are eyeing CSL (ASX:CSL) ahead of its February 11 half year results, with last year's profit guidance downgrade, the delayed Seqirus spin off and weaker US flu vaccinations still shaping sentiment. See our latest analysis for CSL. CSL shares recently saw a 1-day share price return of a 1.15% decline to A$180.19. However, the 7-day and 30-day share price returns of 2.32% and 3.83% suggest some near term momentum after a weak year, with a 1-year total shareholder return of a 33.75%...

Hot Chili (ASX:HCH) has drawn fresh attention after releasing its first 2026 drilling update from the La Verde copper gold discovery in Chile, outlining technical progress and early modelling for potential open pit material. See our latest analysis for Hot Chili. That drilling update has landed in a period of strong momentum for Hot Chili, with a 1 month share price return of 43.59%, a 3 month share price return of 104.17% and a 1 year total shareholder return of 196.01%, pointing to rising...

Northern Star Resources (ASX:NST) moved after record gold prices coincided with the company lifting its FY26 all in sustaining cost forecast and addressing recent operational issues, giving investors fresh information on margins and reliability. See our latest analysis for Northern Star Resources. Beyond this update, Northern Star Resources has been active on the corporate front, including a recent boardroom change with a new Joint Company Secretary and an upcoming AME Roundup presentation...

REA Group (ASX:REA) is back in focus after a volatile spell tied to a failed UK acquisition and fresh competition from Google testing property listings, with recent attention shifting toward its core business and digital mortgage push. See our latest analysis for REA Group. At around A$190.76, REA Group’s recent 7 day share price return of 5.04% and 30 day share price return of 3.72% sit against a 90 day share price decline of 10.77% and a 1 year total shareholder return of 21.98% in the red...

Electro Optic Systems Holdings recently reported a much stronger December 2025 quarter, with higher customer receipts, positive cash generation and a very large increase in its firm contract backlog, supported by defence orders across Australia, NATO markets, South America and the U.S. At the same time, the agreed acquisition of MARSS’s counter‑drone Command‑and‑Control business adds AI-enabled software to EOS’s hardware portfolio, pushing it toward fully integrated counter‑drone...

Woodside Energy Group recently reported unaudited fourth-quarter 2025 revenue of US$3,035 million, down from US$3,484 million a year earlier, alongside a slight dip in quarterly production. Despite the softer quarter, full-year 2025 production edged higher to 198.8 Mboe/d and the company issued 2026 production guidance of 172–186 MMboe, giving investors fresh data on its operational trajectory. We’ll now explore how Woodside’s softer quarterly revenue but higher annual production shapes...

In mid-January 2026, 4DMedical Limited completed a follow-on equity offering of A$79.06 million, issuing 20,806,185 new ordinary shares at A$3.80 each, after holding a special call to explain the capital raise. The company highlighted that the funds from this institutional placement will support the U.S. rollout of its CT:VQ™ lung imaging product, expand deployments in leading hospitals, and further its software-based respiratory imaging research efforts. We will now examine how this...

Guzman y Gomez has exited DoorDash and entered into an exclusive multi-year partnership making Uber Eats its sole third-party delivery platform in Australia, a move announced prior to today and now in effect. This shift consolidates Guzman y Gomez’s delivery channel under one provider, potentially reshaping customer access, operational coordination and bargaining power in the delivery ecosystem. We’ll now examine how concentrating all third-party delivery through Uber Eats could influence...

Vulcan Energy Resources Limited recently reported successful production test results from its first new Lionheart well in Germany’s Upper Rhine Valley Brine Field, confirming strong well deliverability that supports the Phase One Field Development Plan and its goal of producing 24,000 tonnes of lithium hydroxide monohydrate annually by 2028. This outcome, combined with the project being fully funded since December 2025, strengthens confidence in Vulcan’s ability to supply lithium to the...

Fortescue (ASX:FMG) shareholders have approved the acquisition of the remaining shares in Alta Copper. The decision clears the way for full ownership of the copper explorer and further copper-focused activity. The move is part of Fortescue’s broader resource development plans beyond its core iron ore business. Fortescue is best known for its iron ore operations, but copper has become a focus area as demand for materials linked to electrification and energy infrastructure remains in the...

Australian shares are poised for another advance, buoyed by a strong rally on Wall Street and anticipation around upcoming inflation data. This positive momentum provides an intriguing backdrop for exploring investment opportunities in the Australian market. Although the term "penny stocks" may seem outdated, these smaller or newer companies can still offer significant growth potential when backed by solid financials. In this article, we will examine several penny stocks that stand out for...

Key Insights Chrysos' significant retail investors ownership suggests that the key decisions are influenced by...

Mesoblast (ASX:MSB) is back in focus after reporting early commercial experience with Ryoncil in children with steroid refractory acute graft versus host disease, along with broader US access and reimbursement progress. See our latest analysis for Mesoblast. That clinical and reimbursement progress comes after a mixed year for the stock, with a 7.17% 90 day share price return, a 7.24% 30 day share price decline, and a very large 3 year total shareholder return of 198.64%. This suggests longer...

Regulatory concerns and recent share price moves Santana Minerals (ASX:SMI) has come under pressure after reports of a sharp single day share price drop on the NZX, following doubts about how quickly fast track consents for its central Otago gold project will be processed. See our latest analysis for Santana Minerals. While the 1 day share price return declined 9% and the 7 day share price return also weakened, the 30 day and 90 day share price returns of 16% and 37% sit alongside a 1 year...

Alvo Minerals Limited ( ASX:ALV ) insiders who bought shares over the past year were rewarded handsomely last week. The...

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Future Metals...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Star Combo Pharma's (ASX:S66) stock is up by a considerable 17% over the past week. Since the market usually pay for a...

Key Insights Significantly high institutional ownership implies Megaport's stock price is sensitive to their trading...

Key Insights Using the 2 Stage Free Cash Flow to Equity, XRF Scientific fair value estimate is AU$2.04 XRF Scientific's...